286 related articles for article (PubMed ID: 20703031)
1. Antivascular endothelial growth factor in diabetic retinopathy.
Iacono P; Battaglia Parodi M; Bandello F
Dev Ophthalmol; 2010; 46():39-53. PubMed ID: 20703031
[TBL] [Abstract][Full Text] [Related]
2. Evidence for anti-VEGF treatment of diabetic macular edema.
Bandello F; Berchicci L; La Spina C; Battaglia Parodi M; Iacono P
Ophthalmic Res; 2012; 48 Suppl 1():16-20. PubMed ID: 22907145
[TBL] [Abstract][Full Text] [Related]
3. Anti-VEGF therapeutic approaches for diabetic macular edema.
Khurana RN; Do DV; Nguyen QD
Int Ophthalmol Clin; 2009; 49(2):109-19. PubMed ID: 19349791
[No Abstract] [Full Text] [Related]
4. Diabetic macular edema.
Lang GE
Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
[TBL] [Abstract][Full Text] [Related]
5. Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.
Giuliari GP; Guel DA; Cortez MA; Cortez RT
Can J Ophthalmol; 2010 Oct; 45(5):501-8. PubMed ID: 20648074
[TBL] [Abstract][Full Text] [Related]
6. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
7. Recent clinically relevant highlights from the Diabetic Retinopathy Clinical Research Network.
Krick TW; Bressler NM
Curr Opin Ophthalmol; 2018 May; 29(3):199-205. PubMed ID: 29528861
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic retinopathy with anti-VEGF drugs.
Waisbourd M; Goldstein M; Loewenstein A
Acta Ophthalmol; 2011 May; 89(3):203-7. PubMed ID: 21044274
[TBL] [Abstract][Full Text] [Related]
9. A review of clinical trials of anti-VEGF agents for diabetic retinopathy.
Nicholson BP; Schachat AP
Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):915-30. PubMed ID: 20174816
[TBL] [Abstract][Full Text] [Related]
10. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
Ajlan RS; Silva PS; Sun JK
Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
[TBL] [Abstract][Full Text] [Related]
11. Review of anti-VEGF therapy in proliferative diabetic retinopathy.
Jardeleza MS; Miller JW
Semin Ophthalmol; 2009; 24(2):87-92. PubMed ID: 19373692
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF Molecules for the Management of Diabetic Macular Edema.
Bandello F; Cicinelli MV; Parodi MB
Curr Pharm Des; 2015; 21(32):4731-7. PubMed ID: 26350530
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenesis drugs in diabetic retinopathy.
Jeganathan VS
Curr Pharm Biotechnol; 2011 Mar; 12(3):369-72. PubMed ID: 20939797
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Parravano M; Menchini F; Virgili G
Cochrane Database Syst Rev; 2009 Oct; (4):CD007419. PubMed ID: 19821414
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of anti-VEGF agents for diabetic macular edema.
Ollendorf DA; Colby JA; Pearson SD
Int J Technol Assess Health Care; 2013 Oct; 29(4):392-401. PubMed ID: 24290332
[TBL] [Abstract][Full Text] [Related]
16. Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors.
Chong V
Ophthalmologica; 2012; 227 Suppl 1():2-10. PubMed ID: 22517120
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.
Zehetner C; Kirchmair R; Huber S; Kralinger MT; Kieselbach GF
Br J Ophthalmol; 2013 Apr; 97(4):454-9. PubMed ID: 23385630
[TBL] [Abstract][Full Text] [Related]
18. Treatment of proliferative diabetic retinopathy with anti-VEGF agents.
Salam A; Mathew R; Sivaprasad S
Acta Ophthalmol; 2011 Aug; 89(5):405-11. PubMed ID: 21294854
[TBL] [Abstract][Full Text] [Related]
19. CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA.
Hirano T; Toriyama Y; Iesato Y; Imai A; Murata T
Retina; 2018 Sep; 38(9):1801-1808. PubMed ID: 29280940
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for diabetic retinopathy.
Arevalo JF; Garcia-Amaris RA
Curr Diabetes Rev; 2009 Feb; 5(1):39-46. PubMed ID: 19199897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]